Age-related Macular Degeneration

Showing 26 - 50 of 333

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Age-Related Macular Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy Trial in New York (OCT Imaging Using

Not yet recruiting
  • Age-Related Macular Degeneration
  • +5 more
  • OCT Imaging Using Device N
  • OCT Imaging Using Device C
  • New York, New York
    NYU Langone Health
Jan 6, 2023

Following Intensive Anti-VEGF Therapy in Wet AMD

Completed
  • Age-Related Macular Degeneration
  • Budapest, Hungary
  • +1 more
Dec 28, 2022

Age-Related Macular Degeneration Trial in Hong Kong (Expressive Arts-Based Intervention)

Not yet recruiting
  • Age-Related Macular Degeneration
  • Expressive Arts-Based Intervention
  • Hong Kong, Hong Kong
    Centre on Behavioral Health, The University of Hong Kong
Jan 6, 2023

Age-related Macular Degeneration Trial in Coimbra (Blood draw and urine collection)

Completed
  • Age-related Macular Degeneration
  • Blood draw and urine collection
  • Coimbra, Portugal
    AIBILI
Jan 6, 2023

Age-Related Macular Degeneration, Pachychoroid Neovasculopathy Trial (Brolucizumab Injection [Beovu])

Not yet recruiting
  • Age-Related Macular Degeneration
  • Pachychoroid Neovasculopathy
  • Brolucizumab Injection [Beovu]
  • (no location specified)
Dec 21, 2022

Age-Related Macular Degeneration Trial in Beijing (KH631)

Not yet recruiting
  • Age-Related Macular Degeneration
  • Beijing, China
    Beijing Tongren Hospital, Capital Medical University
Jan 3, 2023

Age-Related Macular Degeneration Trial in Rotterdam (Standard lifestyle recommendations + dietary supplementation, Risk

Recruiting
  • Age-Related Macular Degeneration
  • Standard lifestyle recommendations + dietary supplementation
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Dec 19, 2022

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • +2 more
  • Intravitreal aflibercept injection
  • Seoul, Korea, Republic of
    Jae Hui Kim
Dec 20, 2022

Age-Related Macular Degeneration Trial (KH631)

Not yet recruiting
  • Age-Related Macular Degeneration
  • (no location specified)
Dec 10, 2022

A Single-Site Tissue Repository Providing Annotated Biospecimens

Recruiting
  • Age-Related Macular Degeneration
  • +46 more
  • Specimen sample
  • Waltham, Massachusetts
    Sanguine Biosciences
Nov 22, 2022

Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

Recruiting
  • Retinal Disease
  • +17 more
  • Arm 1
  • Westport, Connecticut
  • +2 more
Nov 25, 2022

Age-related Macular Degeneration, Geographic Atrophy Trial (VOY-101)

Recruiting
  • Age-related Macular Degeneration
  • Geographic Atrophy
  • VOY-101
  • Bellaire, Texas
    Retina Consultants of Texas
Nov 17, 2022

OKKO Health Hyperacuity, Contrast and Colour Game Validation in

Recruiting
  • Age-Related Macular Degeneration
    • Bristol, United Kingdom
      Bristol
    Nov 16, 2022

    Intravitreal Injection, Ocular Rinse, Age-Related Macular Degeneration Trial in Oklahoma City (OSDI questionnaire, SPEEDII

    Completed
    • Intravitreal Injection
    • +4 more
    • OSDI questionnaire
    • SPEEDII questionnaire
    • Oklahoma City, Oklahoma
      Dean McGee Eye Institute
    Nov 7, 2022

    Age-related Macular Degeneration Trial in Israel, United States (OpRegen)

    Completed
    • Age-Related Macular Degeneration
    • OpRegen
    • (no location specified)
    Nov 1, 2022

    Functional Optical Coherence Tomography for Ocular Imaging

    Completed
    • Glaucoma
    • +4 more
    • Optical Coherence Tomography
    • Irvine, California
      Beckman Laser Institute, University of California,Irvine
    Oct 19, 2022

    Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Tehran (Aflibercept (CinnaGen Co, Iran),

    Completed
    • Age-Related Macular Degeneration
    • Neovascular Age-related Macular Degeneration
    • Aflibercept (CinnaGen Co, Iran)
    • Aflibercept (Regeneron, USA)
    • Tehran, Iran, Islamic Republic of
      Farabi Hospital
    Oct 16, 2022

    Visual Impairment, Age-Related Macular Degeneration, Diabetic Retinopathy Trial in New York (In-House Developed VR Platform -

    Recruiting
    • Visual Impairment
    • +3 more
    • In-House Developed VR Platform - AMD, DR, Glaucoma
    • In-House Developed VR Platform - Glaucoma
    • New York, New York
      NYU Langone Health
    Oct 6, 2022

    Age-Related Macular Degeneration Trial run by the NEI (Minocycline)

    Active, not recruiting
    • Age-Related Macular Degeneration
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Sep 22, 2022

    Age-Related Macular Degeneration Trial in United States (Iptacopan (LNP023), Placebo)

    Recruiting
    • Age-Related Macular Degeneration
    • Iptacopan (LNP023)
    • Placebo
    • Sacramento, California
    • +9 more
    Sep 20, 2022

    Age-Related Macular Degeneration Trial (Loteprednol Etabonate Ophthalmic Gel [Lotemax], Nepafenac Ophthalmic 0.3% Ophthalmic

    Not yet recruiting
    • Age-Related Macular Degeneration
    • Loteprednol Etabonate Ophthalmic Gel [Lotemax]
    • +2 more
    • (no location specified)
    Sep 14, 2022

    Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial in

    Recruiting
    • Age-Related Macular Degeneration
    • +2 more
    • i-Lumen(TM) AMD
    • i-Lumen(TM) AMD Sham
    • Phoenix, Arizona
    • +2 more
    Sep 1, 2022

    Photobiomodulation, Age-Related Macular Degeneration Trial (Valeda machine)

    Not yet recruiting
    • Photobiomodulation
    • Age-Related Macular Degeneration
    • Valeda machine
    • (no location specified)
    Aug 22, 2022

    Study of Dark Adaptation in Age-Related Macular Degeneration

    Recruiting
    • Age-Related Macular Degeneration
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Age-Related Macular Degeneration Trial in Odessa, Kyiv, Mykolaiv (Subtenon injection of 40 mg triamcinolone acetonide,

      Completed
      • Age-Related Macular Degeneration
      • Subtenon injection of 40 mg triamcinolone acetonide
      • +8 more
      • Odessa, Please Select, Ukraine
      • +3 more
      Aug 21, 2022